US Supreme Court mulls Amgen bid to revive cholesterol drug patents
WASHINGTON - Amgen Inc sought to convince the U.S. Supreme Court on Monday to revive patents on its cholesterol-lowering drug Repatha, while rival Sanofi SA urged the justices not to stifle competition for therapies to address a common health risk.
The case carries considerable financial stakes. Thousand Oaks, California-based Amgen sold nearly $1.3 billion worth of Repatha worldwide in 2022. Meanwhile, Sanofi and Regeneron last year sold $530 million worth worldwide of their rival drug Praluent, which works by a similar mechanism as Repatha. Clement urged the court not to squeeze out competition from the market for cholesterol-lowering drugs.Clement said allowing Amgen's broad patents would freeze out other companies.
"Several times you referred to invention of the antibodies, and I think I'm somewhat confused as to exactly what your invention is. You said it's not just the 26 but it definitely is not millions. So what is it exactly?" conservative Justice Clarence Thomas asked Lamken."We're not talking about what has been invented with any particular precision."
Amgen sued Sanofi and Regeneron in 2014 for patent infringement over Praluent. Both drugs use laboratory-made antibodies to block a protein called PCSK9 that inhibits the removal of bad cholesterol from the blood, but they achieve this result through different chemical combinations.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
U.S. Supreme Court mulls Amgen bid to revive cholesterol drug patentsU.S. Supreme Court justices on Monday weighed a bid by Amgen Inc to revive patents on its cholesterol-lowering drug Repatha in a legal effort that rival Sanofi SA called a 'blatant attempt' to squeeze competitors out of the market.
Lire la suite »
U.S. Supreme Court hears Amgen bid to revive cholesterol drug patentsThe U.S. Supreme Court on Monday began hearing a bid by Amgen Inc to revive patents on its cholesterol-lowering drug Repatha in a legal effort that rival Sanofi SA called a 'blatant attempt' to squeeze competitors out of the market.
Lire la suite »
Mexico government to challenge Supreme Court suspension of electoral reformThe Mexican government said Sunday it would challenge the Supreme Court's temporary suspension of parts of a controversial electoral reform pushed by President Andres Manuel Lopez Obrador.
Lire la suite »
'Poop-themed dog toys' face Supreme Court showdown in trademark disputeThe Supreme Court to debate whether Jack Daniel's has to grin and bear it over humorous dog 'poop-themed' toys that bear a resemblance to its iconic whiskey bottles.
Lire la suite »
Supreme Court chews on Jack Daniel’s dog toy disputeThe question for the court has to do with whether the toy makers infringed on Jack Daniel’s trademarks.
Lire la suite »
US Supreme Court examines law against encouraging illegal immigrationThe U.S. Supreme Court on Monday will consider whether a federal law that made it a crime for a person to encourage illegal immigration violates constitutional free speech protections in a case involving a California man who deceived immigrants through a phony 'adult adoption' program.
Lire la suite »